Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 71.27M 62.71M 58.28M 53.51M 100M 6.88B 102M 692M 270M 3.37B 268M 262M 11.67B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 62.15M 54.68M 50.82M 46.66M 87.58M 6B 89.05M 604M 236M 2.94B 233M 228M 10.18B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2026-02-08 | |
| Director of Finance/CFO | - | 2026-04-15 | |
Kyle Okamoto
PSD | President | - | 2026-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 2020-02-18 |
Charles L. Nuzum
CHM | Chairman | 78 | 2026-02-08 |
| Director/Board Member | 60 | 2020-07-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 71.27M | ||
| +1.07% | -3.49% | -3.25% | +12.87% | 46.86B | ||
| +0.25% | +1.65% | +408.41% | +629.49% | 40.23B | ||
| -0.27% | +4.45% | +9.93% | +66.92% | 36.23B | ||
| +0.35% | +0.87% | +3.60% | -8.81% | 34.72B | ||
| +3.14% | +1.02% | +3.37% | +38.15% | 27.89B | ||
| -0.73% | +11.84% | +31.97% | +143.53% | 16.79B | ||
| +0.47% | -2.74% | - | - | 16.74B | ||
| +0.42% | -5.52% | +0.76% | +8.50% | 13.12B | ||
| -2.68% | -2.49% | -15.00% | -31.68% | 12.7B | ||
| Average | -0.55% | +0.83% | +54.97% | +107.37% | 27.25B | |
| Weighted average by Cap. | +0.48% | +0.91% | +75.32% | +136.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.43M 1.33M 1.22M 2.29M 157M 2.33M 15.77M 6.16M 76.86M 6.1M 5.96M 266M | 125K 110K 102K 94.06K 177K 12.1M 180K 1.22M 475K 5.93M 470K 460K 20.52M |
| Net income | -12.66M -11.14M -10.36M -9.51M -17.85M -1.22B -18.15M -123M -48.03M -599M -47.54M -46.52M -2.07B | -233M -205M -191M -175M -328M -22.51B -334M -2.26B -884M -11.03B -875M -856M -38.18B |
| Net Debt | 1.4M 1.23M 1.14M 1.05M 1.97M 135M 2M 13.56M 5.3M 66.09M 5.24M 5.13M 229M | -9.12M -8.03M -7.46M -6.85M -12.86M -881M -13.07M -88.62M -34.61M -432M -34.25M -33.51M -1.49B |
Employees
-

















